KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Intangibles (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Intangibles for 17 consecutive years, with $174.3 million as the latest value for Q4 2025.

  • Quarterly Intangibles fell 40.63% to $174.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $174.3 million through Dec 2025, down 40.63% year-over-year, with the annual reading at $174.3 million for FY2025, 40.63% down from the prior year.
  • Intangibles for Q4 2025 was $174.3 million at Bio-Rad Laboratories, down from $388.4 million in the prior quarter.
  • The five-year high for Intangibles was $396.9 million in Q2 2025, with the low at $174.3 million in Q4 2025.
  • Average Intangibles over 5 years is $286.0 million, with a median of $307.2 million recorded in 2024.
  • The sharpest move saw Intangibles soared 83.57% in 2022, then crashed 40.63% in 2025.
  • Over 5 years, Intangibles stood at $253.9 million in 2021, then soared by 30.8% to $332.1 million in 2022, then dropped by 3.49% to $320.5 million in 2023, then fell by 8.39% to $293.6 million in 2024, then plummeted by 40.63% to $174.3 million in 2025.
  • According to Business Quant data, Intangibles over the past three periods came in at $174.3 million, $388.4 million, and $396.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.